| Unadjusted HR (95% CI) | P-value |
---|---|---|
Composite endpoint | Â | Â |
Q2 versus Q1 | 1.13 (0.80–1.60) | 1.0000 |
Q3 versus Q1 | 1.61 (1.16–2.23) | 0.0120 |
Q3 versus Q2 | 1.42 (1.03–1.96) | 0.0954 |
Cardiac mortality | Â | Â |
Q2 versus Q1 | 0.85 (0.42–1.66) | 1.0000 |
Q3 versus Q1 | 1.59 (0.89–2.88) | 0.3531 |
Q3 versus Q2 | 1.88 (1.01–3.61) | 0.1338 |
HF re-admission | Â | Â |
Q2 versus Q1 | 1.12 (0.79–1.60) | 1.0000 |
Q3 versus Q1 | 1.50 (1.08–2.11) | 0.0504 |
Q3 versus Q2 | 1.34 (1.08–2.11) | 0.2454 |